Skip to content

Study to Evaluate the Use of Ultrasound in the Diagnosis of Hemophilic Joint Disease

Evaluation of the Role of Power Doppler Sonography in the Diagnosis of Hemophilic Joint Disease

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00212485
Enrollment
43
Registered
2005-09-21
Start date
2005-09-30
Completion date
2009-05-31
Last updated
2010-07-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Inherited Bleeding Disorders

Keywords

Hemophilia, Factor Deficiency, synovitis, sonogram

Brief summary

The purpose of this study is to see whether power Doppler sonography (PDS) can be used to diagnose synovitis in patients with inherited bleeding disorders.

Detailed description

Aim #1 - To determine if PDS can be used to diagnose synovial hypertrophy and inflammation in joint disease associated with inherited bleeding disorders. MRI will be used as a reference standard. Aim #2 - To determine if PDS can be used to assess therapeutic response to treatment. Aim #3 - To determine if PDS can be used as a screening tool for diagnosing early synovitis.

Interventions

PROCEDUREPower Doppler Sonography

Power Doppler with gray-scale sonography is used to detect and quantify alterations in vascularity inside knee, elbow and ankle joints.

PROCEDUREMRI

Magnetic Resonance Imaging with intravenous gadolinium contrast will be done using a standardized protocol, including a spin echo T2 weighted image and gradient echo images.

Sponsors

Bayer
CollaboratorINDUSTRY
New York Presbyterian Hospital
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
1 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* Diagnosis of inherited bleeding disorder For Aim 1: * Age of at least 6 years * History of at least 4 bleeds in the same joint in the preceding 6 months * Joint swelling, synovitis or deformity For Aim 2: * Meet inclusion criteria for Aim 1 and will be having a synovectomy For Aim 3: * Age of at least 1 year * Have had at least 2 joint bleeds

Exclusion criteria

* Not meeting inclusion criteria

Design outcomes

Primary

MeasureTime frame
Comparison of magnetic resonance imaging (MRI) and power Doppler sonograms on patients with target jointUp to 1 month
Evaluation of PDS on patients with target joints pre and post synovectomy to assess response to therapeutic intervention1. day of synovectomy; 2. 6 months post synovectomy.
Evaluation of PDS on patients with at least 2 joint bleeds to diagnose early synovitis1 day

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026